Insulin mutations in diabetes: The clinical spectrum

Diabetes

Volumn 57, Issue 4, 2008, Pages 799-800

  Glaser, Benjamin ^a,b  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INSULIN;

CELL FUNCTION; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN GENE; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; GENETICS; INFANT; NEWBORN; ONSET AGE;

AGE OF ONSET; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; MUTATION, MISSENSE;

EID: 42449143869     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0116     Document Type: Note

References (20)

1. Vaxillaire M, Froguel P: Genetic basis of maturity-onset diabetes of the young. Endocrinol Metab Clin North Am 35:371-384, 2006
2. Hamilton-Shield JP: Overview of neonatal diabetes. Endocr Dev 12:12-23, 2007
3. Njolstad PR, Sovik O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F, Undlien DE, Shiota C, Magnuson MA, Molven A, Matschinsky FM, Bell GI: Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588-1592, 2001
4. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849, 2004
5. Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P: Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456-466, 2006
6. Stoy J, Edghill EL, Flanagan SE, Ye H, Paz VP, Pluzhnikov A, Below JE, Hayes MG, Cox NJ, Lipkind GM, Lipton RB, Greeley SA, Patch AM, Ellard S, Steiner DF, Hattersley AT, Philipson LH, Bell GI: Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci USA 104:15040-15044, 2007
7. Polak M, Dechaume A, Cave H, Nimri R, Crosnier H, Sulmont V, de Kerdanet M, Scharfmann R, Lebenthal Y, Froguel P, Vaxillaire M: Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy. Diabetes 57:1115-1119, 2008
8. Molven A, Ringdal M, Nordb0 AM, Ræder H, St0y J, Lipkind GM, Steiner DF, Philipson LH, Bergmann I, Aarskog D, Undlien DE, G Joner, Søvik O, the Norwegian Childhood Diabetes Study Group, Bell GI, Njølstad PR: Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes 57:1131-1135, 2008
9. Edghill EL, Flanagan SE, Patch AM, Boustred C, Parrish A, Shields B, Shepherd MH, Hussain K, Kapoor RR, Malecki M, Macdonald MJ, Stoy J, Steiner DF, Philipson LH, Bell GI, Hattersley AT, Ellard S: Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57:1034-1042, 2008
10. + channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 56:1930-1937, 2007
11. Bell GI, Pictet RL, Rutter WJ, Cordell B, Tischer E, Goodman HM: Sequence of the human insulin gene. Nature 284:26-32, 1980
12. Chan SJ, Seino S, Gruppuso PA, Schwartz R, Steiner DF: A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia. Proc Natl Acad Sci USA 84:2194-2197, 1987
13. Warren-Perry MG, Manley SE, Ostrega D, Polonsky K, Mussett S, Brown P, Turner RC: A novel point mutation in the insulin gene giving rise to hyperproinsulinemia. J Clin Endocrinol Metab 82:1629-1631, 1997
14. Shibasaki Y, Kawakami T, Kanazawa Y, Akanuma Y, Takaku F: Posttrans-lational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia. J Clin Invest 76:378-380, 1985
15. Yano H, Kitano N, Morimoto M, Polonsky KS, Imura H, Seino Y: A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto). J Clin Invest 89:1902-1907, 1992
16. Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, Steiner D, Rubenstein A, Tager H: Three mutant insulins in man. Nature 302:540-543, 1983
17. Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H: Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proc Natl Acad Sci USA 80:7390-7394, 1983
18. Nanjo K, Sanke T, Miyano M, Okai K, Sowa R, Kondo M, Nishimura S, Iwo K, Miyamura K, Given BD, et al: Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama): clinical and functional characteristics of [LeuA3] insulin. J Clin Invest 77:514-519, 1986
19. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC: Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226-230, 1998
20. Zung A, Glaser B, Nimri R, Zadik Z: Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 89:5504-5507, 2004